Cleared Traditional

K896264 - MILLAR MIKRO-TIP DOPPLER CATHETER

K896264 is the FDA 510(k) clearance for MILLAR MIKRO-TIP DOPPLER CATHETER by Millar Instruments, Inc.. It is a Class 2 Cardiovascular device (product code JOP) cleared through the Traditional 510(k) pathway after a 85-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1990
Decision
85d
Days
Class 2
Risk

K896264 is an FDA 510(k) clearance for the MILLAR MIKRO-TIP DOPPLER CATHETER. Classified as Transducer, Ultrasonic (product code JOP), Class II - Special Controls.

Submitted by Millar Instruments, Inc. (Houston, US). The FDA issued a Cleared decision on January 24, 1990 after a review of 85 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2880 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Millar Instruments, Inc. devices

Submission Details

510(k) Number K896264 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 31, 1989
Decision Date January 24, 1990
Days to Decision 85 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
40d faster than avg
Panel avg: 125d · This submission: 85d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JOP Transducer, Ultrasonic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2880
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - JOP Transducer, Ultrasonic

All 27
Devices cleared under the same product code (JOP) and FDA review panel - the closest regulatory comparables to K896264.
Falcon/Xpress (Falcon/Xpress)
K242662 · Viasonix , Ltd. · Dec 2024
VasoGuard (V10, V8, V6, V4, V2)
K233976 · Corvascular Diagnostics, LLC · Jul 2024
UST-2266U-5 CW DOPPLER TRANSDUCER
K905369 · Ge Medical Systems Information Technologies · Feb 1991
CARDIAC COMPUTATION SOFTWARE PACKAGE
K890636 · Elscint, Inc. · Aug 1989
VOLUME COMPUTATION SOFTWARE PACKAGE
K890638 · Elscint, Inc. · Aug 1989
TRANSESOPHAGEAL ECHO TRANSDUCER
K883889 · General Electric Co. · Nov 1988